PHYSICIANS ARE IGNORING DTC DRUG ADS, STUDY CONCLUDES

Published Online: Thursday, March 1, 2007
Follow Pharmacy_Times:

The pharmaceutical industry's heavy spending on direct-to-consumer (DTC) drug advertising may not be paying off by increasing sales for the promoted products, reported researchers at the Medical University of South Carolina.

Although the study found that the television ads made patients more aware of medications such as Pfizer's Celebrex (celecoxib) and Merck's withdrawn drug Vioxx (rofecoxib), the researchers uncovered little evidence that physicians actually were prescribing more of the advertised drugs. The researchers called that finding good news, noting that it suggests that the effects of DTC advertising may not be as "pernicious" as many critics feared.




Related Articles
No Result Found
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$
VSEO N/A